The Texas abortion ban was reinstated Friday after the U.S. 5th Circuit Court of Appeals blocked a temporary injunction made by a federal judge earlier that week.
Senate Bill (SB) 8, the most restrictive anti-abortion legislation in the U.S., bans almost all abortions after 6 weeks of pregnancy, even in cases of sexual assault, rape, and abuse.
The injunction was ordered October 6 by U.S. District Judge Robert L. Pitman, who said the state was “pursuing an unprecedented and aggressive scheme to deprive its citizens of a significant and well-established constitutional right.”
The U.S. 5th Circuit Court of Appeals restored the enforcement of SB 8 after Texas asked the court to step into the lawsuit against the state, filed by the U.S. Department of Justice.1
During the time in which the ban was in effect, at least 6 Texas clinics resumed abortion care. Whole Woman’s Health, one of the state’s largest providers, quickly began performing abortions later than the 6-week time frame the ban is trying to prohibit.
The law will be enforced until at least October 12 when the Justice Department’s response is due. The court will then hear arguments from both sides and decide on whether to continue enforcement or once again allow temporary blockings from lower courts.
Texas attorneys asked for an emergency stay, arguing that Pitman’s order “violates the separation of powers at every turn.”
Texas Attorney General Ken Paxton showed his support of the court’s decision on Twitter, writing, “Great news tonight, the Fifth Circuit has granted an administrative stay on #SB8," Paxton tweeted. "I will fight federal overreach at every turn."
Reference
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Reduced subsequent births reported after severe maternal morbidity
November 26th 2024Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More